date,title,source
Oct-29-18,Neurocrine Biosciences (NBIX) Q3 Earnings Preview: What to Look Out For,Zacks
Oct-31-18,Neurocrine (NBIX) to Report Q3 Earnings: What's in the Cards?,Zacks
Nov-05-18,Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates,Zacks
Nov-05-18,Neurocrine: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Neurocrine Biosciences Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-05-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Exelixis,ACCESSWIRE
Nov-07-18,Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference,PR Newswire
Nov-07-18,Does Neurocrine Biosciences Incs (NASDAQ:NBIX) Debt Level Pose A Problem?,Simply Wall St.
Nov-09-18,"Report: Developing Opportunities within Louisiana-Pacific, Neurocrine Biosciences, Tahoe Resources, Loews, Quotient Technology, and Evolent Health  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-14-18,AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress,PR Newswire
Nov-15-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Amarin,ACCESSWIRE
Nov-16-18,Neurocrine (NBIX) Catches Eye: Stock Jumps 6.5%,Zacks
Nov-27-18,3 Top Biotech Stocks to Buy Right Now,Motley Fool
Dec-12-18,"Why Under Armour, Neurocrine Biosciences, and XPO Logistics Slumped Today",Motley Fool
Dec-12-18,Why Neurocrine Biosciences Is Tanking,Motley Fool
Dec-12-18,Neurocrine Biosciences says trial of Tourette syndrome treatment missed primary goal,MarketWatch
Dec-12-18,Neurocrine Biosciences Announces Topline Data from Phase IIb T-Force GOLD Study Demonstrating Valbenazine Did Not Meet Primary Endpoint in Pediatric Patients with Tourette Syndrome,PR Newswire
Dec-13-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Synergy Pharmaceuticals,ACCESSWIRE
